Pfizer Pays Brigham Young U. $450M to Settle Suit
- Quick Takes: Divisions on Gallaudet Board, Students Don't Worry About Professorial Rank, Brigham Young Sues Pfizer, Sociologists Back Evolution, James Madison Parents Complain to NCAA, Eccentric's Art Was Stolen From Harvard, Disputed Study Published
- Drug Warnings Could Protect Students, Too
- 2 Companies Will Pay Emory $525 Million for Drug Royalties
- A lawsuit filed against two labs founded by UT-Austin professor raises questions of conflict of interest and academic freedom
- Ethics and Patents
The pharmaceutical company Pfizer has agreed to pay $450 million to Brigham Young University to settle a lawsuit over the drug Celebrex, The Deseret News reported. Brigham Young and one of its professors have accused the company of unfairly using his work conducted at the university for the drug. The announcement of the settlement did not detail terms, but a footnote in a quarterly report issued by Pfizer references a $450 million expense related to the Brigham Young suit.